ALPHA TEKNOVA, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ALPHA TEKNOVA, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $170.00K, a 962.50% increase year-over-year.
- ALPHA TEKNOVA, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $9.00K.
- ALPHA TEKNOVA, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-12-31 was $51.00K, a 104.00% increase year-over-year.
- ALPHA TEKNOVA, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $29.00K, a 625.00% increase year-over-year.
- ALPHA TEKNOVA, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $100.00K, a 244.83% increase from fiscal 2024.
- ALPHA TEKNOVA, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $29.00K, a 61.84% decline from fiscal 2023.
- ALPHA TEKNOVA, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $76.00K, a 47.59% decline from fiscal 2022.
- ALPHA TEKNOVA, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $145.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $170.00K 10-Q · filed 2026-08-06 | $259.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $9.00K 10-Q · filed 2026-05-07 | $105.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $100.00K 10-K · filed 2026-03-02 |
| 2025-09-30 | $29.00K 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $16.00K 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $29.00K 10-K · filed 2026-03-02 |
| 2024-09-30 | $4.00K 10-Q · filed 2024-11-08 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $76.00K 10-K · filed 2025-03-07 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $87.00K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $67.00K 10-Q · filed 2024-08-13 | $122.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $9.00K 10-Q · filed 2024-05-13 | $99.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $145.00K 10-K · filed 2024-03-27 |
| 2022-09-30 | $35.00K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $44.00K 10-Q · filed 2023-08-11 | |
| 2022-03-31 | $55.00K 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |